Literature DB >> 21593156

Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts.

Jennifer Humberd Smith1, Tamas Nagy, Elizabeth Driskell, Paula Brooks, S Mark Tompkins, Ralph A Tripp.   

Abstract

Virus replication and pulmonary disease pathogenesis in ferrets following intranasal infection with a pandemic influenza virus strain (A/California/4/09 [CA09]), a human seasonal influenza H1N1 virus isolate (A/New Caledonia/20/99 [Ncal99]), a classical swine influenza H1N1 virus isolate (A/Swine/Iowa/15/30 [Sw30]), or an avian H1N1 virus isolate (A/Mallard/MN/A108-2355/08 [Mal08]) were compared. Nasal wash virus titers were similar for Ncal99 and Sw30, with peak virus titers of 10(5.1) 50% tissue culture infectious doses (TCID(50))/ml and 10(5.5) TCID(50)/ml occurring at day 3 postinfection (p.i.), respectively. The mean peak titer for CA09 also occurred at day 3 p.i. but was higher (10(7) TCID(50)/ml). In contrast, the peak virus titers (10(3.6) to 10(4.3) TCID(50)/ml) for Mal08 were delayed, occurring between days 5 and 7 p.i. Disease pathogenesis was characterized by microscopic lesions in the nasal turbinates and lungs of all ferrets; however, Sw30 infection was associated with severe bronchointerstitial pneumonia. The results demonstrate that although CA09 is highly transmissible in the human population and replicates well in the ferret model, it causes modest disease compared to other H1N1 viruses, particularly Sw30 infection.

Entities:  

Mesh:

Year:  2011        PMID: 21593156      PMCID: PMC3147907          DOI: 10.1128/JVI.00512-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

3.  Reactions of antibodies with surface antigens of influenza virus.

Authors:  R G Webster; W G Laver; E D Kilbourne
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

4.  Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.

Authors:  Jessica A Belser; Kortney M Gustin; Taronna R Maines; Dianna M Blau; Sherif R Zaki; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-08       Impact factor: 17.586

6.  Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Authors:  C Y Tai; P A Escarpe; R W Sidwell; M A Williams; W Lew; H Wu; C U Kim; D B Mendel
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

Authors:  Vincent J Munster; Emmie de Wit; Judith M A van den Brand; Sander Herfst; Eefje J A Schrauwen; Theo M Bestebroer; David van de Vijver; Charles A Boucher; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2009-07-02       Impact factor: 47.728

8.  Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero).

Authors:  E A Govorkova; N V Kaverin; L V Gubareva; B Meignier; R G Webster
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

9.  Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.

Authors:  J Carr; J Ives; L Kelly; R Lambkin; J Oxford; D Mendel; L Tai; N Roberts
Journal:  Antiviral Res       Date:  2002-05       Impact factor: 5.970

10.  Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus.

Authors:  Judith M A van den Brand; Koert J Stittelaar; Geert van Amerongen; Guus F Rimmelzwaan; James Simon; Emmie de Wit; Vincent Munster; Theo Bestebroer; Ron A M Fouchier; Thijs Kuiken; Albert D M E Osterhaus
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

View more
  19 in total

1.  H5N1 influenza viruses: facts, not fear.

Authors:  Peter Palese; Taia T Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-25       Impact factor: 11.205

2.  Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.

Authors:  Ian N Moore; Elaine W Lamirande; Myeisha Paskel; Danielle Donahue; Heather Kenney; Jing Qin; Kanta Subbarao
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

3.  A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.

Authors:  Tiffany M Turner; Les P Jones; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

4.  Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.

Authors:  Alaina J Mooney; Jon D Gabbard; Zhuo Li; Daniel A Dlugolenski; Scott K Johnson; Ralph A Tripp; Biao He; S Mark Tompkins
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge.

Authors:  Leo K Sage; Julie M Fox; Andrew L Mellor; Stephen M Tompkins; Ralph A Tripp
Journal:  Viral Immunol       Date:  2014-04-04       Impact factor: 2.257

6.  A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo.

Authors:  Gene S Tan; Florian Krammer; Dirk Eggink; Alita Kongchanagul; Thomas M Moran; Peter Palese
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

7.  Low pathogenic avian influenza isolates from wild birds replicate and transmit via contact in ferrets without prior adaptation.

Authors:  Elizabeth A Driskell; Jennifer A Pickens; Jennifer Humberd-Smith; James T Gordy; Konrad C Bradley; David A Steinhauer; Roy D Berghaus; David E Stallknecht; Elizabeth W Howerth; Stephen Mark Tompkins
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

8.  Influenza Vaccination of Swine Reduces Public Health Risk at the Swine-Human Interface.

Authors:  Joshua N Lorbach; Sarah W Nelson; Sarah E Lauterbach; Jacqueline M Nolting; Eben Kenah; Dillon S McBride; Marie R Culhane; Christa Goodell; Andrew S Bowman
Journal:  mSphere       Date:  2021-06-30       Impact factor: 5.029

9.  The potential of avian H1N1 influenza A viruses to replicate and cause disease in mammalian models.

Authors:  Zeynep A Koçer; Scott Krauss; David E Stallknecht; Jerold E Rehg; Robert G Webster
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets.

Authors:  Judith M A van den Brand; Koert J Stittelaar; Geert van Amerongen; Leslie Reperant; Leon de Waal; Albert D M E Osterhaus; Thijs Kuiken
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.